Author: McKinley Corbley / Source: Good News Network
This groundbreaking new piece of research could offer a life-saving reprieve for people suffering from the constant danger of accidentally being exposed to peanuts.
According to a new study that was published in the New England Journal of Medicine this week, a drug called AR101 has been shown to prevent deadly allergy attacks in patients who are extremely sensitive to peanuts.
“Because there is no approved treatment for peanut allergy, the standard of care has been a strict elimination diet and the timely administration of rescue medications in case of an allergic reaction on accidental exposure,” reads the study.
“However, despite vigilance, accidental exposures may occur and cause reactions of unpredictable severity, even with small amounts of allergen, leading to a lifelong risk of severe reactions.”
MORE: Doctor That Discovered Natural Way to Treat Vertigo for Free Writes Book On How Sufferers Can Thrive
The oral treatment, which was designed by biopharmaceutical company Aimmune Therapeutics, is designed to gradually increase a patient’s tolerance to peanuts over the course of 6 months.
In the study, which is being hailed as the largest and first successful phase 3 peanut allergy immunotherapy trial to date, the drug was given to 555 people between the ages of…
The post New Peanut Allergy Drug Shows Life-Saving Potential – and It Could Be Available as Soon as 2019 appeared first on FeedBox.